Corteva, Inc.
CTVANYSEMaterials · Agricultural Production-Crops · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $17.40B | $16.91B | $17.23B | $17.45B | $15.65B | $14.22B |
| Operating income | — | — | — | — | — | — |
| Net income | $1.09B | $907.0M | $735.0M | $1.15B | $1.76B | $681.0M |
| Total assets | $42.84B | $40.83B | $43.00B | $42.62B | $42.34B | $42.65B |
| Total liabilities | — | — | — | — | — | — |
| Equity | $24.14B | $23.79B | $25.04B | $25.30B | $25.38B | $24.82B |
| EPS (diluted) | $1.60 | $1.30 | $1.03 | $1.58 | $2.37 | $0.91 |
| Shares out. | 685.6M | 701.8M | 712.8M | 727.0M | 744.1M | 749.4M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- 6.3%
- Return on equity
- 4.5%
- Return on assets
- 2.6%
- Return on capital (ROCE)
- —
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $35.22
- Revenue growth (YoY)
- 2.9%
- Net income growth (YoY)
- 20.6%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- −5.4%clean
- Piotroski F-Score
- 5/7mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 3 good- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Capital World InvestorsPassive (13G)May 14, 2026
- Fmr LlcPassive (13G)May 6, 2026
- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- State Street CorpPassive (13G)Nov 10, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Nayyar Nayaki RDirector | Apr 30, 2026 | Grant | 401.185 | $81.01 |
| Lutz Marcos MDirector | Apr 30, 2026 | Tax withholding | 906 | $81.01 |
| Giesselman Janet PlautDirector | Apr 30, 2026 | Grant | 95.667 | $81.01 |
| Engel Klaus ADirector | Apr 30, 2026 | Tax withholding | 906 | $81.01 |
| Everitt David CDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Ward PatDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Preete Kerry JDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Policinski Christopher J.Director | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Nayyar Nayaki RDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Lutz Marcos MDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Grimes Karen H.Director | Apr 28, 2026 | Grant | 2,350 | $0.00 |
| Giesselman Janet PlautDirector | Apr 28, 2026 | Grant | 2,350 | $0.00 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 17.2M | 4.1 | +13.5% |
| Apr 30, 2026 | 15.2M | 5.1 | -6.3% |
| Apr 15, 2026 | 16.2M | 4.4 | +16.2% |
| Mar 31, 2026 | 13.9M | 3.0 | +11.6% |
| Mar 13, 2026 | 12.5M | 3.1 | -2.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 5, 2026
- Shareholder voteMay 1, 2026
- Director / officer change · Regulation FD disclosureApr 14, 2026
- Results of operationsFeb 3, 2026
- Results of operationsNov 4, 2025
- Results of operationsOct 1, 2025
- Director / officer change · Regulation FD disclosureAug 26, 2025
- Results of operationsAug 6, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Corporate family
Spun off from DowDuPontDD · Jun 1, 2019
From the spin-off filings we track. Follow a company to walk its own history.